Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Front Pharmacol ; 13: 905576, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35784734

RESUMEN

Triptolide, a diterpene triepoxide, is a pharmacologically active compound isolated from a Chinese medicinal herb Tripterygium wilfordii Hook F (TwHF). Triptolide has attracted considerable attention in recent times due to its multiple biological and pharmaceutical activities, with an emphasis on therapeutic importance in the treatment of diverse disorders. With essential medicinal implications, TwHF's extracts have been used as anti-inflammatory, antiproliferative, antioxidative, and immunosuppressive agents for centuries, with continuous and relevant modifications to date to enhance its utility in several diseases and pathophysiology. Here, in this review, we accentuate the studies, highlighting the effects of triptolide on treating bone-related disorders, both inflammatory and cancerous, particularly osteosarcoma, and their manifestations. Based on this review, future avenues could be estimated for potential research strategies, molecular mechanisms, and outcomes that might contribute toward reinforcing new dimensions in the clinical application of triptolide in treating bone-related disorders.

2.
Sci Rep ; 11(1): 23319, 2021 12 02.
Artículo en Inglés | MEDLINE | ID: mdl-34857775

RESUMEN

As an important protein source, soybean products can cause intestinal inflammation and injury in many animals including human beings, particularly infants and juvenile individuals. Research in this field has been performed for terrestrial animals and fish, but still lacks integrity and systematicness. In this study, the main biological processes in the intestinal tract of marine fish juvenile pearl gentian grouper in the state of soybean meal-induced enteritis (SBMIE) were analyzed. A total of 720 groupers with an approximate initial weight of 12.5 g were randomly divided into three groups: the fish meal (FM) control group, the 20% SBM group (SBM20), and the SBM40 group (n = 4). Three iso-nitrogenous and iso-lipidic diets were prepared and fed to fish for 10 weeks. Each barrel contained a water volume of about 1 m3 in and was exposed to natural light and temperature. Results indicated that the growth and physiology of groupers fed with SBM were significantly negatively affected, with the gene expressions of intestinal structural protein abnormal. 16SrDNA high-throughput sequencing showed that the intestinal microflora played an important role in the pathogenesis of pearl gentian grouper SBMIE, which may activate a variety of pathogen pattern recognition receptors, such as toll-like receptors (TLRs), RIG-I-like receptors, and nod-like receptors. Transcriptome analysis revealed that changes of the SBMIE signaling pathway in pearl gentian groupers were conservative to some extent than that of terrestrial animals and freshwater fish. Moreover, the TLRs-nuclear factor kappa-B signaling pathway becomes activated, which played an important role in SBMIE. Meanwhile, the signal pathways related to nutrient absorption and metabolism were generally inhibited. Metabolomics analysis showed that isoflavones and saponins accounted for a large proportion in the potential biomarkers of pearl gentian grouper SBMIE, and most of the biomarkers had significantly positive or negative correlations with each other; 56 metabolites were exchanged between intestinal tissues and contents, which may play an important role in the development of enteritis, including unsaturated fatty acids, organic acids, amino acids, vitamins, small peptides, and nucleotides, etc. These results provide a basic theoretical reference for solving the intestinal issues of fish SBMIE and research of inflammatory bowel disease in mammals.


Asunto(s)
Alimentación Animal/análisis , Enteritis/metabolismo , Proteínas de Peces/metabolismo , Glycine max/toxicidad , Intestinos/metabolismo , Metaboloma , Transcriptoma , Animales , Enteritis/inducido químicamente , Enteritis/genética , Proteínas de Peces/genética , Regulación de la Expresión Génica , Intestinos/efectos de los fármacos , Perciformes
3.
Yi Chuan ; 36(11): 1152-8, 2014 Nov.
Artículo en Chino | MEDLINE | ID: mdl-25567873

RESUMEN

Hereditary hemochromatosis (HHC) is a rare autosomal recessive disorder. We recruited a consanguineous Chinese family including the proband with HHC and other four members without HHC. Using whole-exome sequencing, we identified two homozygous mutations (c.G18C [p.Q6H] and c.GC962_963AA [p.C321X]) in the hemojuvelin gene (HJV) in the proband with HHC. No mutation was found in other four previously identified HHC related genes, HAMP, TFR2, FPN and HFE. The functional impact of p.Q6H mutation is weak whereas p.C321X, a premature termination mutation, results in a truncated HJV protein, which lacks the glycosylphosphatidylinositol (GPI) anchor domain. In addition to the mutations in HJV, other 12 homozygous mutations were identified in this patient. However, none of these mutations showed strong damaging impact and the mutated genes are not related to iron metabolism. Our in-house data further demonstrated that p.C321X is absent in the general Chinese population, suggesting that the homozygous mutation p.C321X in HJV is causative in the patient with HHC. Accordingly, all of the four members without HHC from the same family carried wild-type alleles or heterozygous mutations, but not the homozygous mutation in this site. Thus, we found for the first time that the homozygous mutation p.C321X in HJV can result in HHC, which will help genetic diagnosis and prenatal counseling for HHC.


Asunto(s)
Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana/genética , Mutación , Adulto , Exoma , Proteína de la Hemocromatosis , Homocigoto , Humanos , Masculino , Análisis de Secuencia de ADN
4.
Arch Dermatol ; 145(9): 1040-7, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19770446

RESUMEN

OBJECTIVE: To explore the association between hepatitis C virus (HCV) and lichen planus (LP) by performing a meta-analysis of observational studies of the association. Data Sources Bibliographical searches were conducted in the MEDLINE, EMBASE, and China National Knowledge Infrastructure (CNKI) databases without any language limitations. Study Selection Studies were selected when the following criteria were met: the coexistence of a study group and a control group, the reliable and nonselective use of the reference standards for the diagnosis of LP and HCV, and the proportion of events (the prevalence of HCV in patients with LP or the prevalence of LP in patients with HCV). Data Extraction Three investigators independently assessed abstracts for relevant studies, and 2 investigators independently reviewed all eligible studies. Data Synthesis Sixty-three articles entailing 7 studies were included in the meta-analysis. For the primary outcome of prevalence of events, the meta-analysis showed that there existed an important association between HCV and LP. In the comparison of the prevalence of HCV exposure among patients with LP with that of control participants, the odds ratio (OR) was 5.4 (95% confidence interval [CI], 3.5-8.3); in the prevalence of LP among patients with HCV compared with the prevalence among control participants, the OR was 2.5 (95% CI, 2.0-3.1). The subgroup analyses with geographical stratification did not show a significant association in studies from South Asia (P = .21), Africa (P = .15), and North America (P = .09), and the subgroup analyses from stratification by LP type also did not show a significant association in the isolated cutaneous type (P = .17). When strict criteria were applied, the results of sensitivity analysis remained robust. Conclusion Hepatitis C virus infection is associated with a statistically significant risk for development of LP, suggesting that the presence of either HCV or certain types of LP may be used as a predictive marker of the other in certain geographical regions.


Asunto(s)
Hepacivirus/aislamiento & purificación , Hepatitis C/complicaciones , Liquen Plano/etiología , Salud Global , Hepatitis C/epidemiología , Hepatitis C/virología , Humanos , Liquen Plano/epidemiología , Prevalencia
5.
Am J Med Sci ; 338(5): 343-7, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19745703

RESUMEN

BACKGROUND: We investigated the clinical-pathological features and the prognosis of thrombotic thrombocytopenic purpura (TTP) in patients with lupus nephritis (LN). METHODS: A retrospective analysis was performed on the clinical-pathological data and prognosis in 8 patients with LN complicating with TTP. RESULTS: Thrombocytopenia and hemolytic anemia, neurologic symptoms, and renal dysfunction were the clinical manifestations in 8 patients. Six patients had fever. Eight patients presented with rapid progressive glomerulonephritis, and 1 patient with continuous gross hematuria. The histologic features of the 8 patients were thrombotic microangiopathy lesions. Immune-suppressive therapies were administrated in all patients, and blood purification therapy was applied in 7 patients. Three cases involved plasma exchange and/or immunoabsorption. Seven patients received a median follow-up of 12 months. One patient died, 3 cases received peritoneal dialysis, and 1 case failed to follow-up. During follow-up, 1 case was able to stop peritoneal dialysis, and 1 case changed to hemodialysis. The other 3 patients continued with stable renal function. CONCLUSION: The patients with LN with TTP have severe clinical-pathological changes. Active treatment including renal replacement therapy, plasma exchange, and immunoabsorption are promising.


Asunto(s)
Riñón/patología , Nefritis Lúpica/diagnóstico , Púrpura Trombocitopénica Trombótica/diagnóstico , Adolescente , Adulto , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Técnicas de Inmunoadsorción , Inmunosupresores/uso terapéutico , Riñón/irrigación sanguínea , Nefritis Lúpica/complicaciones , Nefritis Lúpica/patología , Nefritis Lúpica/terapia , Masculino , Persona de Mediana Edad , Intercambio Plasmático , Pronóstico , Púrpura Trombocitopénica Trombótica/complicaciones , Púrpura Trombocitopénica Trombótica/patología , Púrpura Trombocitopénica Trombótica/terapia , Terapia de Reemplazo Renal , Estudios Retrospectivos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...